Impact of Factor V Leiden G1691A, MTHFR C677T, and Prothrombin G20210 A mutations on the development of neonatal thrombosis
Mokhtar Ahmed, A., Risha, A., El-Taher, A., Abdelhy, R., M. AbdElmonem, D. (2022). Impact of Factor V Leiden G1691A, MTHFR C677T, and Prothrombin G20210 A mutations on the development of neonatal thrombosis. EKB Journal Management System, 28(5), 1156-1163. doi: 10.21608/zumj.2022.137019.2564
Ahmed Mokhtar Ahmed; Amr I. Risha; Ahmed K. El-Taher; Rabab M Abdelhy; Doaa M. AbdElmonem. "Impact of Factor V Leiden G1691A, MTHFR C677T, and Prothrombin G20210 A mutations on the development of neonatal thrombosis". EKB Journal Management System, 28, 5, 2022, 1156-1163. doi: 10.21608/zumj.2022.137019.2564
Mokhtar Ahmed, A., Risha, A., El-Taher, A., Abdelhy, R., M. AbdElmonem, D. (2022). 'Impact of Factor V Leiden G1691A, MTHFR C677T, and Prothrombin G20210 A mutations on the development of neonatal thrombosis', EKB Journal Management System, 28(5), pp. 1156-1163. doi: 10.21608/zumj.2022.137019.2564
Mokhtar Ahmed, A., Risha, A., El-Taher, A., Abdelhy, R., M. AbdElmonem, D. Impact of Factor V Leiden G1691A, MTHFR C677T, and Prothrombin G20210 A mutations on the development of neonatal thrombosis. EKB Journal Management System, 2022; 28(5): 1156-1163. doi: 10.21608/zumj.2022.137019.2564

Impact of Factor V Leiden G1691A, MTHFR C677T, and Prothrombin G20210 A mutations on the development of neonatal thrombosis

Zagazig University Medical Journal
Article 33, Volume 28, Issue 5, September 2022, Page 1156-1163  XML PDF (519.92 K)
Document Type: Original Article
DOI: 10.21608/zumj.2022.137019.2564
View on SCiNiTO View on SCiNiTO
Authors
Ahmed Mokhtar Ahmed email orcid 1; Amr I. Rishaorcid 2; Ahmed K. El-Taher3; Rabab M Abdelhy4; Doaa M. AbdElmonemorcid 5
1Clinical Pathology department. faculty of medicine, zagazig university
2paediatrics department. faculty of medicine, zagazig university
3Department of General Surgery, Zagazig University Hospitals, Zagazig, Egypt
4Radiology department zagazig University egypt
5Department of clinical pathology, faculty of medicine, zagazig university
Abstract
ABSTRACT
Background: Neonatal thrombosis is a rare disorder usually develops because of underlying conditions in the neonatal period, such as thrombophilia gene mutations, sepsis, congenital heart disease and surgical interventions or intravascular catheters.
Objective: The goal is to look at the prevalence of neonatal thrombophilia and its risk factors among neonates admitted to the Neonatal Intensive Care Unit (NICU).
Patients and methods: A cohort research that took place in neonatal ICUs in Zagazig University Hospitals from January to December 2021. Forty patients were involved. Patients were given a thorough medical history, clinical, neurological examinations, laboratory routine tests and Screening for thrombophilia gene variants by RT-PCR using the Vienna Lab Diagnostics GmbH's (FVL, PTH and MTHFR Strip Assay) ® A kit (Vienna, Austria).
Results: Concerning factor V gene mutation (G1691A) there was 6 (15%) had mutations, four of them (10%) showed heterozygous and two (5%) showed homozygous s mutations while 34 (85%) were normal. Nine (22.5%) patients had mutation of prothrombin G2010A gene with five (12.5%) of them were heterozygous and four (10%) were homozygous while 31 (77.5%) were normal. As regard MTHR C677T, 10 (25%) were normal, 23 (57.5%) had heterogeneous and 7 (17.5%) showed homozygous mutations. There was statistically significant increase in D-dimer and the presence of the Factor V (G1691A) and prothrombin G20210A while it was non-significant as regard mutations of MTHFR C677T.
Conclusion: Neonatal thrombosis is a critical condition. Its incidence increased with the presence of homozygous thrombophilia gene mutations especially with surgical intervention or venous catheterization.
Keywords
Thrombophilia; Neonatal; Thrombosis; Venous thromboembolism (VTE)
Statistics
Article View: 185
PDF Download: 214